Status
Conditions
Treatments
About
Patients with irritable bowel syndrome (IBS) have increased intestinal permeability. In addition, mucosal soluble mediators are involved in the pathophysiology of pain in IBS. The investigators aimed to investigate:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 3 patient groups
Loading...
Central trial contact
Thierry PICHE, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal